Publications

Export 173 results:
[ Auteur(Desc)] Title Type Année
Filtres: First Letter Of Last Name is B  [Enlever les filtres]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
Benoit A, Malla AK, Iyer SN, Joober R, Bherer L, Lepage M.  2015.  Cognitive deficits characterization using the CogState Research Battery in first-episode psychosis patients.. Schizophr Res Cogn. 2(3):140-145.
Bergeron L, Smolla N, Berthiaume C, Renaud J, Breton J-J, St-Georges M, Morin P, Zavaglia E, Labelle R.  2017.  Reliability, Validity, and Clinical Utility of the Dominic Interactive for Adolescents-RevisedA DSM-5-Based Self-Report Screen for Mental Disorders, Borderline Personality Traits, and Suicidality.. Can J Psychiatry. 62(3):211-222.
Bergeron D, Flynn K, Verret L, Poulin S, Bouchard RW, Bocti C, Fülöp T, Lacombe G, Gauthier S, Nasreddine Z et al..  2017.  Multicenter Validation of an MMSE-MoCA Conversion Table.. J Am Geriatr Soc. 65(5):1067-1072.
Berlim M, Van den Eynde F.  2014.  Repetitive transcranial magnetic stimulation over the dorsolateral prefrontal cortex for treating posttraumatic stress disorder: an exploratory meta-analysis of randomized, double-blind and sham-controlled trials.. Can J Psychiatry. 59(9):487-96.
Berlim M, McGirr A, Van den Eynde F, Fleck MPA, Giacobbe P.  2014.  Effectiveness and acceptability of deep brain stimulation (DBS) of the subgenual cingulate cortex for treatment-resistant depression: a systematic review and exploratory meta-analysis.. J Affect Disord. 159:31-8.
Berlim M, Van den Eynde F, Tovar-Perdomo S, Chachamovich E, Zangen A, Turecki G.  2014.  Augmenting antidepressants with deep transcranial magnetic stimulation (DTMS) in treatment-resistant major depression.. World J Biol Psychiatry. 15(7):570-8.
Berlim M, McGirr A, Santos NRodrigues, Tremblay S, Martins R.  2017.  Efficacy of theta burst stimulation (TBS) for major depression: An exploratory meta-analysis of randomized and sham-controlled trials.. J Psychiatr Res. 90:102-109.
Berlim M, van den Eynde F, Tovar-Perdomo S, Daskalakis ZJ.  2014.  Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials.. Psychol Med. 44(2):225-39.
Bernard-Gauthier V, Bailey JJ, Mossine AV, Lindner S, Vomacka L, Aliaga A, Shao X, Quesada CA, Sherman P, Mahringer A et al..  2017.  A Kinome-Wide Selective Radiolabeled TrkB/C Inhibitor for in Vitro and in Vivo Neuroimaging: Synthesis, Preclinical Evaluation, and First-in-Human.. J Med Chem. 60(16):6897-6910.
Bernard-Gauthier V, Aliaga A, Aliaga A, Boudjemeline M, Hopewell R, Kostikov A, Rosa-Neto P, Thiel A, Schirrmacher R.  2015.  Syntheses and evaluation of carbon-11- and fluorine-18-radiolabeled pan-tropomyosin receptor kinase (Trk) inhibitors: exploration of the 4-aza-2-oxindole scaffold as Trk PET imaging agents.. ACS Chem Neurosci. 6(2):260-76.
Bernard-Gauthier V, Mossine AV, Mahringer A, Aliaga A, Bailey JJ, Shao X, Stauff J, Arteaga J, Sherman P, Grand'Maison M et al..  2018.  Identification of [F]TRACK, a Fluorine-18-Labeled Tropomyosin Receptor Kinase (Trk) Inhibitor for PET Imaging.. J Med Chem. 61(4):1737-1743.
Besse C, Poremski D, Laliberté V, Latimer E.  2017.  Changes in the nature and intensity of stress following employment among people with severe mental illness receiving individual placement and support services: an exploratory qualitative study.. J Ment Health. 26(4):312-317.
Besse C, Poremski D, Laliberté V, Latimer E.  2018.  The meaning and experience of stress among supported employment clients with mental health problems.. Health Soc Care Community. 26(3):383-392.
Bhagwat N, Pipitone J, Winterburn JL, Guo T, Duerden EG, Voineskos AN, Lepage M, Miller SP, Pruessner JC, M Chakravarty M.  2016.  Manual-Protocol Inspired Technique for Improving Automated MR Image Segmentation during Label Fusion.. Front Neurosci. 10:325.
Bhardwaj SK, Tse YChung, Ryan R, Wong TPan, Srivastava LK.  2014.  Impaired adrenergic-mediated plasticity of prefrontal cortical glutamate synapses in rats with developmental disruption of the ventral hippocampus.. Neuropsychopharmacology. 39(13):2963-73.
Bhardwaj SK, Ryan RT, Wong TPan, Srivastava LK.  2015.  Loss of dysbindin-1, a risk gene for schizophrenia, leads to impaired group 1 metabotropic glutamate receptor function in mice.. Front Behav Neurosci. 9:72.
Bhardwaj SK, Dodat F, Levesque D, Srivastava LK.  2018.  Altered regulation of Nur77 nuclear receptor gene expression in the mesocorticolimbic regions of rat brain by amphetamine sensitization.. Brain Res.
Bhardwaj SK, Stojkovic K, Kiessling S, Srivastava LK, Cermakian N.  2015.  Constant light uncovers behavioral effects of a mutation in the schizophrenia risk gene Dtnbp1 in mice.. Behav Brain Res. 284:58-68.
Bhat V, Joober R, Sengupta SM.  2017.  How Environmental Factors Can Get Under the Skin: Epigenetics in Attention-Deficit/Hyperactivity Disorder.. J Am Acad Child Adolesc Psychiatry. 56(4):278-280.
Bhat V, Leong K, Lee J, Voineskos D, Daskalakis ZJ, Lam RW, Jollant F.  2014.  Research-track programs for residents in psychiatry: a review of literature and a report of 3 Canadian experiences.. Can J Psychiatry. 59(5):268-75.
Bier N, Grenier S, Brodeur C, Gauthier S, Gilbert B, Hudon C, Lepage E, Ouellet M-C, Viscogliosi C, Belleville S.  2015.  Measuring the impact of cognitive and psychosocial interventions in persons with mild cognitive impairment with a randomized single-blind controlled trial: rationale and design of the MEMO+ study.. Int Psychogeriatr. 27(3):511-25.
Bimpisidis Z, König N, Stagkourakis S, Zell V, Vlcek B, Dumas S, Giros B, Broberger C, Hnasko TS, Wallén-Mackenzie Å.  2019.  The NeuroD6 Subtype of VTA Neurons Contributes to Psychostimulant Sensitization and Behavioral Reinforcement.. eNeuro. 6(3)
Bischoff AR, Pokhvisneva I, Léger É, Gaudreau H, Steiner M, Kennedy JL, O'Donnell K, Diorio J, Meaney MJ, Silveira PP.  2017.  Dynamic interaction between fetal adversity and a genetic score reflecting dopamine function on developmental outcomes at 36 months.. PLoS One. 12(5):e0177344.
Bisht K, Sharma KP, Lecours C, Sánchez MGabriela, Hajj HEl, Milior G, Olmos-Alonso A, Gómez-Nicola D, Luheshi G, Vallières L et al..  2016.  Dark microglia: A new phenotype predominantly associated with pathological states.. Glia. 64(5):826-39.
Blackhall F, Kim D-W, Besse B, Nokihara H, Han J-Y, Wilner KD, Reisman A, Iyer SN, Hirsh V, Shaw AT.  2014.  Patient-reported outcomes and quality of life in PROFILE 1007: a randomized trial of crizotinib compared with chemotherapy in previously treated patients with ALK-positive advanced non-small-cell lung cancer.. J Thorac Oncol. 9(11):1625-33.

Pages